首页> 外国专利> NOVEL (2-HALOGEN-ERGOLINYL)-N',N'-DIETHYLUREA DERIVATIVE, MANUFACTURE AND DOPAMINE, NORADRENALINE AND SEROTONIN MEDICINE CONTAINING SAME

NOVEL (2-HALOGEN-ERGOLINYL)-N',N'-DIETHYLUREA DERIVATIVE, MANUFACTURE AND DOPAMINE, NORADRENALINE AND SEROTONIN MEDICINE CONTAINING SAME

机译:新型(2-卤代-麦角酰)-N',N'-二乙脲衍生物,制造和多巴胺,去甲肾上腺素和5-羟色胺的含量相同

摘要

(2-Haloergolinyl)-N',N'-diethylurea derivatives of Formula I IMAGE (I) and the salts thereof, wherein R is hydrogen, alkyl of up to 6 carbon atoms, or alkenyl of up to 3 carbon atoms, X is halogen, IMAGE is a CC single or CC double bond, and the urea residue in the 8-position can be in the alpha - or beta -configuration, have neuropsychotropic properties. As a result, they are excellently suitable for treatment of psychotic disturbances and emesis.
机译:式I (I)的(2-卤代麦角烷基)-N',N'-二乙基脲衍生物及其盐,其中R为氢,至多6个碳原子的烷基或至多3个碳原子的烯基, X是卤素,是CC单键或CC双键,并且在8位的尿素残基可以处于α-或β-构型,具有神经精神特性。结果,它们非常适合治疗精神病和呕吐。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号